CDH1 and cervical cancer: Here, we observed that Ecadherin is a direct target of miR-375 in cervical cancer cells; moreover, re-expression of Ecadherin partly reversed the EMT phenotype and paclitaxel -resistance induced by miR-375 in cervical cancer cells.